CAPRICOR THERAPEUTICS, INC. Paid-in-Kind Interest
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Paid-in-Kind Interest of $498.86 thousand for the 98-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2013-11-14
- CAPRICOR THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2013-09-30 was $60.63K.
- CAPRICOR THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2013-06-30 was $74.05K.
- CAPRICOR THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2013-03-31 was $13.02K.
- CAPRICOR THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2012-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. paid-in-kind interest for fiscal 2012 was $0.00.
- CAPRICOR THERAPEUTICS, INC. paid-in-kind interest for fiscal 2011 was $0.00.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month | Paid-in-Kind Interest 71 month | Paid-in-Kind Interest 74 month | Paid-in-Kind Interest 77 month | Paid-in-Kind Interest 80 month | Paid-in-Kind Interest 83 month | Paid-in-Kind Interest 86 month | Paid-in-Kind Interest 89 month | Paid-in-Kind Interest 92 month | Paid-in-Kind Interest 95 month | Paid-in-Kind Interest 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $60.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $134.68K derived: sum of 2 quarters · filed 2013-11-14 | $147.70K 10-Q · filed 2013-11-14 | $147.70K derived: sum of 4 quarters · filed 2013-11-14 | $498.86K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $74.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $87.06K 10-Q · filed 2013-08-14 | $87.06K derived: sum of 3 quarters · filed 2013-08-14 | $87.06K derived: sum of 4 quarters · filed 2013-11-14 | $438.23K 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $13.02K 10-Q · filed 2013-06-21 | $13.02K derived: sum of 2 quarters · filed 2013-06-21 | $13.02K derived: sum of 3 quarters · filed 2013-11-14 | $13.02K derived: sum of 4 quarters · filed 2013-11-14 | $364.18K 10-Q · filed 2013-06-21 | |||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 derived: sum of 3 quarters · filed 2013-11-14 | $0.00 10-K · filed 2013-06-21 | $351.17K 10-K · filed 2013-06-21 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | $351.17K 10-Q · filed 2013-06-21 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-08-14 | $351.17K 10-Q/A · filed 2012-09-10 | ||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-06-21 | $351.17K 10-Q/A · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 10-K · filed 2013-06-21 | $351.17K 10-K · filed 2012-04-02 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2013-06-21 | $351.17K 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $351.17K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |